ABSTRACT The widely held view that transfused bone marrow cells will not proliferate in normal mice, not exposed to irradiation or other forms of bone marrow ablation, was reinvestigated. Forty million bone marrow cells from male donors were given to female recipients on each of 5 consecutive days, 5 to 10 times the number customarily used in the past. When the recipients were examined 2-13 weeks after the last transfusion, donor cells were found to average 16-25% of total marrow cells. Similar percentages ofdonor cells were found when variants ofthe enzyme phosphoglycerate kinase determined electrophoretically were used for identification of donor and recipient cells. Evidence is presented that the proportion of donor cells is compatible with a linear dependence on the number of cells transfused over the range tested-i.e., million bone marrow cells injected intravenously. Special proliferative sites thus do not appear to be required.
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There is a long-standing presumption that intravenously transfused marrow cells proliferate only to a minimal extent, even in congeneic mice (1) (2) (3) . However, Saxe et aL (4) recently reported the replacement of 10% of marrow cells by donor cells after transfusion of 100 million marrow cells in 5 daily aliquots of 20 million given intravenously, though not after intraperitoneal injection.
We have confirmed the substantial proliferation of donor marrow cells after multiple large transfusions. The results appear of particular interest because they make unnecessary the assumption of special proliferative sites for stem cells [colonyforming units, spleen (CFU-S)] thought to be filled in normal marrow and thus precluding seeding of transfused CFU-S (1).
MATERIALS AND METHODS
Most of the experiments were with CBA mice. To trace the origin ofproliferating bone marrow cells after transfusion, bone marrows of female recipients of cells from male donors were analyzed cytologically for the presence of the Y chromosome as described (3, 5) . Suspensions of bone marrow were prepared in phosphate-buffered saline and counted in a Coulter Counter, and the desired number of cells was given intravenously in 0.5 ml of phosphate-buffered saline.
Further experiments were performed using donors and recipients carrying A and B alleles of the X chromosome locus PGK-1 of phosphoglycerate kinase (EC 2.7.2.3); the products of these alleles differ in electrophoretic mobility (6) . The PGK-1A variant, on a predominantly C3H genetic background, was kindly donated by John West (Oxford University) and was backcrossed onto the CBA/Ca (PGK-1B) genetic background for nine generations. After electrophoretic separation of the two variant enzymes, densitometry provided the percentages of donor and host cells in the recipients' bone marrow or other organs. Full details of the method, modified from that of Buecher et aL (7), will be published elsewhere. Briefly, cell suspensions were prepared in RPMI-1640 medium, centrifuged at 150 X g, and exposed to a 10-sec distilled water shock to lyse the erythrocytes (8) . After one washing the cell pellet was resuspended in 50 mM triethanolamine HCI buffer (pH 7.6) saturated with digitonin and containing dithioerythritol at 0.3 mg/ liter and bovine serum albumin at 0.5 mg/liter and stored at -600C.
After appropriate dilution in dithioerythritol/bovine serum albumin buffer containing 67% (vol/vol) glycerol, samples were electrophoresed 3.5-4 hr at 200 V on 16 x 17 cm Cellogel sheets (Helena Laboratories, Beaumont, TX), using a cooled tank and a bridge distance of 9 cm. The electrophoresis buffer was 20 mM sodium barbital/10 mM trisodium citrate/5 mM sodium sulfate/2 mM EDTA, pH 8.8. To this, dithioerythritol was added at 0.01% before use. AMP (free acid) was added to the cathodal buffer at 0.036%.
Immediately after electrophoresis, the gel was exposed to a "staining" mixture essentially as described by Buecher et al.
(7) but including also "GC-labeled glucose (Amersham, specific activity 303 mCi/mmol; 1 Ci = 3.7 x 1010 becquerels), 15 ,Ci per gel. Next 1.45 ml was spread on a polyethyleneimine sheet (Bakerflex) on which the gel was then laid. The principle was to provide the unstable substrate 1,3-diphosphoglycerate for PGK, and to feed the ATP formed during the conversion to 3-phosphoglycerate into the hexokinase/glucose-6-phosphate dehydrogenase pathway, catalyzing the production of glucose 6-phosphate and 6-phosphogluconolactone from glucose. These products were radiolabeled owing to the inclusion of ["'C]glucose as substrate and became covalently bound to the polyethyleneimine sheet by their phosphate groups (9) . The 14C activity over each of the two bands of PGK was proportional to the enzyme activity present. Autoradiographs were prepared on x-ray (Kodak XS) or gravure (Kodak 4513) film and scanned in a semiautomatic densitometer and integrator (Joyce-Loebl Instruments, Gateshead, England). The figures obtained were corrected to allow for the log-linear response of the photographic emulsion.
RESULTS
The results of marrow transfusions from male donors to female recipients are summarized in The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. with the rarity with which circulating CFU-S reenter the marrow (17) . The forcefully liberated bone marrow CFU-S are thus a population sui generis as already evident from earlier experiments in which we showed that they lodge preferentially in the marrow on reinfusion (3) .
In retrospect it will be realized that most of the literature on experimental bone marrow transfusion contains no rigid controls, because only irradiated or otherwise marrow-depressed animals have been used as recipients. The notable exception is the use of unirradiated WWv mice in which their own defective stem cells are replaced gradually after transfusion of congeneic marrow. The advantage in both instances is that inocula of a few hundred thousand bone marrow cells corresponding to a few hundred CFU-S suffice to obtain extensive proliferation of donor cells. In lethally irradiated animals the small inocula of normal cells assure survival and lead to apparently complete restoration of a normal marrow. However, the irradiated environment may be expected to modify the behavior of proliferating cells. The present demonstration of effective proliferation of transfused bone marrow cells in normal recipients now makes possible a systematic investigation of possible microenvironmental or other influences resulting from the routine use of marrow depressants in experimental bone marrow transplantation.
